Skip to main content
NCBI home page
Proceedings of the National Academy of Sciences of the United States of America logoLink to Proceedings of the National Academy of Sciences of the United States of America
. 1989 Jun;86(12):4690–4694. doi: 10.1073/pnas.86.12.4690

Estimation of glucose carbon recycling in children with glycogen storage disease: A 13C NMR study using [U-13C]glucose.

B Kalderon 1, S H Korman 1, A Gutman 1, A Lapidot 1
PMCID: PMC287337  PMID: 2734314

Abstract

A stable isotope procedure to estimate hepatic glucose carbon recycling and thereby elucidate the mechanism by which glucose is produced in patients lacking glucose 6-phosphatase is described. A total of 10 studies was performed in children with glycogen storage disease type I (GSD-I) and type III (GSD-III) and control subjects. A primed dose-constant nasogastric infusion of D-[U-13C]glucose (greater than 99% 13C-enriched) or an infusion diluted with nonlabeled glucose solution was administered following different periods of fasting. Hepatic glucose carbon recycling was estimated from 13C NMR spectra. The recycling parameters were derived from plasma beta-glucose C-1 splitting pattern, doublet/singlet values of plasma glucose C-1 in comparison to doublet/singlet values of known mixtures of [U-13C]glucose and unlabeled glucose as a function of 13C enrichment of glucose C-1. The fractional glucose C-1 enrichment of plasma glucose samples was analyzed by 1H NMR spectroscopy and confirmed by gas chromatography/mass spectroscopy. The values obtained for GSD-I patients coincided with the standard [U-13C]glucose dilution curve. These results indicate that the plasma glucose of GSD-I subjects comprises only a mixture of 99% 13C-enriched D-[U-13C]glucose and unlabeled glucose but lacks any recycled glucose. Significantly different glucose carbon recycling values were obtained for two GSD-III patients in comparison to GSD-I patients. Our results eliminate a mechanism for glucose production in GSD-I children involving gluconeogenesis. However, glucose release by amylo-1,6-glucosidase activity would result in endogenous glucose production of non-13C-labeled and nonrecycled glucose carbon, as was found in this study. In GSD-III patients gluconeogenesis is suggested as the major route for endogenous glucose synthesis. The contribution of the triose-phosphate pathway in these patients has been determined. The significant difference of the glucose C-1 splitting pattern in plasma GSD-III and control subjects, in comparison to GSD-I plasma, can be used as a parameter for estimating glucose recycling. This approach can be developed as a noninvasive diagnostic test for inborn enzymatic defects involving gluconeogenesis.

Full text

PDF
4690

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bier D. M., Arnold K. J., Sherman W. R., Holland W. H., Holmes W. F., Kipnis D. M. In-vivo measurement of glucose and alanine metabolism with stable isotopic tracers. Diabetes. 1977 Nov;26(11):1005–1015. doi: 10.2337/diab.26.11.1005. [DOI] [PubMed] [Google Scholar]
  2. Cahill G. F., Jr Starvation in man. N Engl J Med. 1970 Mar 19;282(12):668–675. doi: 10.1056/NEJM197003192821209. [DOI] [PubMed] [Google Scholar]
  3. Gagnaire D. Y., Taravel F. R. Biosynthèse de cellulose bactérienne à partir de D-glucose uniformément enrichi en 13C. Eur J Biochem. 1980 Jan;103(1):133–143. doi: 10.1111/j.1432-1033.1980.tb04297.x. [DOI] [PubMed] [Google Scholar]
  4. Inbar L., Lapidot A. Metabolic regulation in Streptomyces parvulus during actinomycin D synthesis, studied with 13C- and 15N-labeled precursors by 13C and 15N nuclear magnetic resonance spectroscopy and by gas chromatography-mass spectrometry. J Bacteriol. 1988 Sep;170(9):4055–4064. doi: 10.1128/jb.170.9.4055-4064.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Inbar L., Lapidot A. The structure and biosynthesis of new tetrahydropyrimidine derivatives in actinomycin D producer Streptomyces parvulus. Use of 13C- and 15N-labeled L-glutamate and 13C and 15N NMR spectroscopy. J Biol Chem. 1988 Nov 5;263(31):16014–16022. [PubMed] [Google Scholar]
  6. Kalderon B., Gopher A., Lapidot A. Metabolic pathways leading to liver glycogen repletion in vivo, studied by GC-MS and NMR. FEBS Lett. 1986 Aug 11;204(1):29–32. doi: 10.1016/0014-5793(86)81381-3. [DOI] [PubMed] [Google Scholar]
  7. Kalderon B., Lapidot A., Korman S. H., Gutman A. Glucose recycling and production in children with glycogen storage disease type I, studied by gas chromatography/mass spectrometry and (U-13C)glucose. Biomed Environ Mass Spectrom. 1988 Oct;16(1-12):305–308. doi: 10.1002/bms.1200160158. [DOI] [PubMed] [Google Scholar]
  8. Lapidot A., Nissim I. Regulation of pool sizes and turnover rates of amino acids in humans: 15N-glycine and 15N-alanine single-dose experiments using gas chromatography-mass spectrometry analysis. Metabolism. 1980 Mar;29(3):230–239. doi: 10.1016/0026-0495(80)90064-5. [DOI] [PubMed] [Google Scholar]
  9. Schoots A. C., Leclercq P. A. Chemical ionization mass spectrometry of trimethylsilylated carbohydrates and organic acids retained in uremic serum. Biomed Mass Spectrom. 1979 Nov;6(11):502–507. doi: 10.1002/bms.1200061109. [DOI] [PubMed] [Google Scholar]
  10. Schwenk W. F., Haymond M. W. Optimal rate of enteral glucose administration in children with glycogen storage disease type I. N Engl J Med. 1986 Mar 13;314(11):682–685. doi: 10.1056/NEJM198603133141104. [DOI] [PubMed] [Google Scholar]
  11. Tsalikian E., Simmons P., Gerich J. E., Howard C., Haymond M. W. Glucose production and utilization in children with glycogen storage disease type I. Am J Physiol. 1984 Oct;247(4 Pt 1):E513–E519. doi: 10.1152/ajpendo.1984.247.4.E513. [DOI] [PubMed] [Google Scholar]

Articles from Proceedings of the National Academy of Sciences of the United States of America are provided here courtesy of National Academy of Sciences

RESOURCES